Christine Arcari, PhD, MPH, serves as a member of the SCVD Executive Committee. Dr. Arcari is an Associate Professor at the University of Texas Medical Branch Galveston in the Department of Preventive Medicine & Community Health and holds the Robert E. Shope M.D. Professorship in Infectious Disease Epidemiology. She received her PhD in epidemiology from the Johns Hopkins Bloomberg School of Public Health, and an MPH in Community and Family Health from the University of South Florida, College of Public Health. Currently, Dr. Arcari serves as the Director of the Public Health Graduate Program which provides students with the knowledge, skills, and values needed to succeed in careers that bridge medicine, research and public health. Dr. Arcari has an extensive record of teaching, mentoring and promoting student success. The primary courses she teaches are "Introduction to Epidemiology" and "Epidemiology of Infectious Diseases". In recognition of the quality of her educational efforts she was awarded the 2010, 2015 and 2016 UTMB Graduate School of Biomedical Sciences Teaching Excellence Award for Population Health Sciences and holds a Distinguished Teaching Professor title for the UTMB Academy of Master Teachers. Her scholarly activities are focused in the areas of creating healthier communities and public health education, with an emphasis on cultivating academic-practice partnerships. She has built strong academic-community partnerships as co-founder of the Research, Education and Community Health Coalition (REACH) community advisory board. This board brings together community leaders from Galveston County with UTMB scientists to inform research development and implementation across the translational spectrum and to impact community health and wellness through community intervention and dissemination of best practices.
Alan DT Barrett, PhD, serves as Director of the SCVD. As such, Dr. Barrett provides scientific direction for the SCVD's research programs. He is a world-renowned expert in the biology of flaviviruses. His research efforts have led to forty extramurally funded projects. He has published over 150 peer-reviewed journal articles - most of which are related to the molecular characterization/development of vaccines. He completed his 5-year term as an editor of the Journal of General Virology in December 2009 and became an Associate Editor for the journal Vaccine in January 2010. He is a member of the editorial boards of Journal of Virology, Journal of General Virology, Journal of Virological methods, Virus Research, Journal of Medical Virology and the Pan Amazonian Health Journal. He spent five years on the World Health organization (WHO) Advisory Committee for vaccines against dengue and other flavivirus diseases, including four years as chair. He has been a member of a number of WHO working groups for yellow fever, dengue, Japanese encephalitis and tick-borne encephalitis vaccines, and is a member of the Virus Diseases Panel of the Department of Defense Military Infectious Diseases Research program. In addition, Dr. Barrett is the Director of the WHO Collaborating Center for Vaccine Research, Evaluation and Training on Emerging Infectious Diseases (WHO CC).
Diane Barrett, MSc, CCRP
Diane Barrett, MSc, CCRP, serves as a member of the SCVD Executive Committee. Ms. Barrett trained as a registered nurse at the Nightingale School of Nursing, St. Thomas’ Hospital, London and received her BS and MS degrees from the University of Southampton in the UK. She also obtained a post-registration certification and practiced as a Registered Health Visitor for several years before moving to Galveston, Texas in 1993. Ms. Barrett joined the SCVD Clinical Trials Group (CTG) as a Clinical Research Coordinator in October 2002, became a Senior Clinical Research Coordinator in 2004, and now has 14 years of federal and industry-sponsored vaccine clinical trials experience. In her current position as Research Project Manager for the SCVD CTG, she is responsible for administrative support, oversight of financial management, contract facilitation, assisting the principal investigator with preparation and submission of sponsor-required reports, quality management and the day-to-day supervision and management of the study team.
David WC Beasley, PhD, serves as a member of the SCVD Executive Committee. Dr. Beasley is an internationally recognized expert in the field of molecular biology of flaviviruses. His research focuses on the plasticity of flavivirus envelope protein sequences and the molecular basis for phenotypic variations between individual strains and major groups of flaviviruses, with the goal of developing and evaluating new and improved vaccines, diagnostics and therapeutics. He also served as a Co-Director of the University of Texas Medical Branch's (UTMB's) select agent BSL-3 laboratories and was the Director of the Galveston National Laboratory Regulatory Compliance Core. Dr. Beasley has been actively involved in UTMB's preparations for conduct of regulated nonclinical studies at BSL3/4 since 2005, with an emphasis on development and use of animal models for testing and approval of new vaccines and therapeutics under the FDA's Animal Rule. In addition, Dr. Beasley is the Associate Director of the WHO Collaborating Center for Vaccine Research, Evaluation and Training on Emerging Infectious Diseases (WHO CC).
Krystyn Z Bourne, PhD
Krystyn Z Bourne, PhD, serves as Assistant Director and as a member of the Executive Committee for the SCVD. She is responsible for organizing and monitoring the research and operational activities; maintaining contacts with external organizations that have an interest in SCVD programs. She also assembles information required for SCVD profiles, annual reports, and internal and external reviews and manages special projects such as a distance learning course development, pre- and postdoctoral fellowship applications, and an annual seminar series and recurring symposia. In addition, Dr. Bourne assists with website maintenance and serves as Assistant Editor for the online journal, npj Vaccines.
Andrew G McNees, PhD, MBA
Andrew G McNees, PhD, MBA, serves as Director, Administration, and as a member of the Executive Committee for the SCVD. He is responsible for serving as a liaison with various entities both on campus and off; overseeing budgets and support staff; preparing grants, contracts, reports and manuscripts; facilitating the ordering of supplies and equipment; and organizing logistics support for the center as a whole. In addition, Dr. McNees compiles data and reports the status of ongoing projects to Dr. Barrett for review.
Gregg N Milligan, PhD, serves as a member of the SCVD Executive Committee. He is an expert in the field of viral immunology and currently directs NIH-funded research projects dealing with identification of protective correlates of immunity against genital herpes virus infections and with the link between innate and adaptive immune responses in flavivirus infections. Dr. Milligan is active in the education of graduate and medical students.
Lisa M Reece, PhD
Lisa M Reece, PhD, serves as Assistant Director for the WHO Collaborating Center for Vaccine Research, Evaluation and Training on Emerging Infectious Diseases (WHO CC) and as a member of the SCVD Executive Committee. She is responsible for helping to manage and organize the WHO CC Internship Program. To that end, she helps recruit graduate/medical students for the internships and generates and maintains protocols for the student interns to follow that will help them navigate the intern process. She organizes and maintains communication between the WHO CC and collaborators. In addition, Dr. Reece manages WHO CC annual reports and maintains the intern database.
Richard Rupp, MD is the Director of Clinical Trials and Clinical Research and a member of the Executive Committee for the SCVD. He leads the SCVD Clinical Trials Group, and is a Principal Investigator for clinical trials, Phase I to IV, in both pediatric and adult populations. Vaccines studied have included those protecting against human cytomegalovirus, seasonal, avian and pandemic influenza, pneumococcal disease, human papillomavirus, Dengue, varicella, Herpes simplex 2, and meningococcal disease.
Pei-Yong Shi, PhD, serves as a member of the SCVD Executive Committee. Dr. Shi has pioneered flavivirus drug discovery in leading pharmaceutical companies and academia. He is also an internationally recognized leader in the field of flavivirus biology and vaccine development. He has published over 210 peer-reviewed articles and served as Editor (ACS Infectious Diseases, Journal of General Virology, and NPJ Vaccine) and Editorial Board member (Journal of Virology, Virology, and Antiviral Research). Dr. Shi’s lab integrates both academic and industrial expertise for basic and translational research.